Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase

James E Dunford, Aaron A Kwaasi, Michael J Rogers, Bobby L Barnett, Frank H Ebetino, R Graham G Russell, Udo Oppermann, Kathryn L Kavanagh

Research output: Contribution to journalArticle

114 Citations (Scopus)


The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs. Disruption of the phosphonate-carbon-phosphonate backbone resulted in loss of potency and reduced K(isom). The lack of a hydroxyl group on the geminal carbon also reduced K(isom). The position of the nitrogen in the side chain was crucial to both K(i) and K(isom). A correlation of K(isom) and also final K(i) with previously published in vivo potency reveals that the isomerization constant ( R = -0.77, p <0.0001) and the final inhibition of FPPS by N-BPs ( R = 0.74, p <0.0001) are closely linked to antiresorptive efficacy.
Original languageEnglish
Pages (from-to)2187-2195
Number of pages9
JournalJournal of Medicinal Chemistry
Issue number7
Early online date8 Mar 2008
Publication statusPublished - Jul 2008



  • Binding Sites
  • Diphosphonates
  • Enzyme Inhibitors
  • Geranyltranstransferase
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Nitrogen
  • Stereoisomerism
  • Structure-Activity Relationship
  • Time Factors

Cite this